Skip to main content
Clinical Trials/NCT01184625
NCT01184625
Unknown
Not Applicable

Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation

Karolinska Institutet1 site in 1 country30 target enrollmentJanuary 2008
ConditionsMyositis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myositis
Sponsor
Karolinska Institutet
Enrollment
30
Locations
1
Primary Endpoint
Hypoxia related metabolites.
Last Updated
14 years ago

Overview

Brief Summary

The objectives of this study are to test if hypoxia in muscle tissue is an important factor contributing to clinical symptoms in chronic rheumatic muscle inflammation and to evaluate if a 12 week endurance exercise program will improve muscle tissue hypoxia and disability in patients with chronic rheumatic muscle inflammation.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
August 2012
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic, stable polymyositis or dermatomyositis with diagnosis of definite or probable polymyositis or dermatomyositis (Bohan and Peter 1975)
  • Age 18-80 years
  • Duration since diagnosis \> 6 months
  • Exercising \< once a week,
  • Stable disease activity and medication for at least one month.
  • Ten healthy controls matched for age, gender and physical exercise level will be included.

Exclusion Criteria

  • Severe pulmonary fibrosis
  • Heart or lung conditions that contraindicate vigorous exercise
  • Severe osteoporosis
  • Not being able to perform the exercise program.

Outcomes

Primary Outcomes

Hypoxia related metabolites.

Time Frame: After 12 weeks of endurance exercise intervention/ non intervention.

Secondary Outcomes

  • Muscle impairment.(After 12 weeks of endurance exercise intervention/ non intervention.)

Study Sites (1)

Loading locations...

Similar Trials